Investors

Insider Transactions

Date Name Title Type Shares Traded Price Range Sorted Ascending
Jun 10, 2013 baker charles a Director Option Execute 15,000 15.80
Jul 1, 2011 brown michael s Director Option Execute 25,000 15.80 - 28.81
Mar 1, 2012 brown michael s Director Option Execute 20,000 15.80 - 19.69
Aug 7, 2012 gilman alfred g Director Option Execute 15,000 15.80
Feb 10, 2011 goldstein joseph l Director Option Execute 5,000 15.80
Jan 26, 2011 goldstein joseph l Director Option Execute 10,000 15.80
Jan 21, 2010 shooter eric m Director Option Execute 15,000 15.80
Feb 21, 2014 sing george l Director Option Execute 15,000 15.80
Dec 16, 2008 yancopoulos george Officer Automatic Sell 74,859 16.40 - 16.42
Aug 1, 2013 goldberg murray a Officer Option Execute 5,000 16.80
Feb 6, 2012 goldberg murray a Officer Option Execute 40,913 16.80 - 24.86
May 20, 2013 goldberg murray a Officer Option Execute 147,967 16.80 - 53.18
May 21, 2013 goldberg murray a Officer Option Execute 4,023 16.80 - 20.32
Dec 17, 2012 mccorkle douglas s Officer Option Execute 5,000 16.80
Feb 14, 2012 mccorkle douglas s Officer Option Execute 35,000 16.80 - 21.92
Jul 25, 2012 powchik peter Officer Option Execute 15,000 16.80
Jan 9, 2013 powchik peter Officer Option Execute 5,752 16.80 - 21.25
Sep 18, 2012 powchik peter Officer Option Execute 15,000 16.80
Sep 18, 2013 roberts william Officer Option Execute 15,000 16.80
Feb 14, 2012 stahl neil Officer Option Execute 50,000 16.80
Showing 221-240 of 790 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)